TMPRSS2 and cancer: proposed that altered expression of TMPRSS2 in cancer patients could influence cytokine production upon SARS‐CoV‐2 infection, potentially exacerbating the risk of a cytokine storm—a hyperinflammatory response leading to severe tissue damage and organ failure [52].